Back
Black Diamond Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63
BDTX
Black Diamond Therapeutics
Last Price:
$3.22
Seasonality Move:
-29.92%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Black Diamond Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.86 | Buy |
| 20-day SMA: | 2.62 | Buy |
| 50-day SMA: | 2.33 | Buy |
| 200-day SMA: | 2.38 | Buy |
| 8-day EMA: | 2.91 | Buy |
| 20-day EMA: | 2.69 | Buy |
| 50-day EMA: | 2.4 | Buy |
| 200-day EMA: | 2.6 | Buy |
Black Diamond Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 77.09 | Buy |
| Chaikin Money Flow: | 517630 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.32 - 2.82) | Buy |
| Bollinger Bands (100): | (1.55 - 2.45) | Buy |
Black Diamond Therapeutics Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
-
Black Diamond Therapeutics share price is 3.21 while BDTX 8-day simple moving average is 2.86, which is a Buy signal.
-
The stock price of BDTX is 3.21 while Black Diamond Therapeutics 20-day SMA is 2.62, which makes it a Buy.
-
Black Diamond Therapeutics 50-day simple moving average is 2.33 while BDTX share price is 3.21, making it a Buy technically.
-
BDTX stock price is 3.21 and Black Diamond Therapeutics 200-day simple moving average is 2.38, creating a Buy signal.
BDTX Technical Analysis vs Fundamental Analysis
Buy
63
Black Diamond Therapeutics (BDTX)
is a Buy
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a BuyThe current Black Diamond Therapeutics [BDTX] share price is $3.21. The Score for BDTX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
182.5M
Price in USD:
3.21
Share Volume:
988.2K
Black Diamond Therapeutics 52-Week Range
52-Week High:
6.75
52-Week Low:
1.20
Buy
63
Black Diamond Therapeutics (BDTX)
is a Buy
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?The Black Diamond Therapeutics stock price is 3.21 USD today.
-
Will BDTX stock go up or go down?Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Black Diamond Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is not overvalued.
Is Black Diamond Therapeutics Stock a Buy?
-
Black Diamond Therapeutics share price is 3.21 while BDTX 8-day exponential moving average is 2.91, which is a Buy signal.
-
The stock price of BDTX is 3.21 while Black Diamond Therapeutics 20-day EMA is 2.69, which makes it a Buy.
-
Black Diamond Therapeutics 50-day exponential moving average is 2.40 while BDTX share price is 3.21, making it a Buy technically.
-
BDTX stock price is 3.21 and Black Diamond Therapeutics 200-day simple moving average is 2.60, creating a Buy signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.08 per share, an increase this year of $1.53 per share, and a decrease next year of $0.97 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
-
BDTX Moving Average Covergence Divergence (MACD) indicator is 0.2, suggesting Black Diamond Therapeutics is a Buy
-
Black Diamond Therapeutics Relative Strength Index (RSI) is 77.09, which suggest Black Diamond Therapeutics is overbought
-
The Bollinger Bands (25) for Black Diamond Therapeutics is (2.32 - 2.82), which suggest Black Diamond Therapeutics is a Buy
-
The Bollinger Bands (100) for Black Diamond Therapeutics is (1.55 - 2.45), which suggest Black Diamond Therapeutics is a Buy
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.